4893 items matching your search terms.

Symptom burden and outcomes of patients with platinum resistant/refractory recurrent ovarian cancer: a reality check: results of stage 1 of the Gynecologic Cancer Intergroup Symptom Benefit study

Friedlander, M. L. Stockler, M. O'Connell, R. Voysey, M. Oza, A. Gillies, K. Donovan, H. Martyn, J. Sjoquist, K. Butow, P. King, M. T. Symptom Benefit Study Group,
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014     DOI:10.1097/IGC.0000000000000147

Cost-effectiveness of primary care referral to a commercial provider for weight loss treatment, relative to standard care-a modelled lifetime analysis

Fuller, N.R. Carter, H. Schofield, D. Hauner, H. Jebb, S.A. Colagiuri, S. Caterson, I.D.
INTERNATIONAL JOURNAL OF OBESITY, 2014     DOI:10.1038/ijo.2013.227

Changes in physical activity during a weight loss intervention and follow-up: a randomized controlled trial

Fuller, N. R. Williams, K. Shrestha, R. Ahern, A. L. Holzapfel, C. Hauner, H. Jebb, S. A. Caterson, I. D.
CLINICAL OBESITY, 2014     DOI:10.1111/cob.12057

Midregional proadrenomedullin and its change predicts recurrent major coronary events and heart failure in stable coronary heart disease patients: the LIPID study

Funke-Kaiser, A. Mann, K. Colquhoun, D. Zeller, T. Hunt, D. Simes, J. Sullivan, D. Sydow, K. West, M. White, H. Blankenberg, S. Tonkin, A. M. on behalf of the LIPID Study Investigators,
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2014     DOI:10.1016/j.ijcard.2014.01.064

Selective internal radiation therapy (SIRT) with yttrium-90 resin microspheres plus standard systemic chemotherapy regimen of FOLFOX versus FOLFOX alone as first-line treatment of non-resectable liver metastases from colorectal cancer: the SIRFLOX study

Gibbs, P. Gebski, V. Van Buskirk, M. Thurston, K. Cade, D. N. Van Hazel, G. A.
BMC CANCER, 2014     DOI:10.1186/1471-2407-14-897

Which lipid measurement should we monitor? An analysis of the LIPID study

Glasziou, P.P. Irwig, L. Kirby, A.C. Tonkin, A.M. Simes, R.J.
BMJ OPEN, 2014     DOI:10.1136/bmjopen-2013-003512

Metabolic mediators of the effect of body mass index, overweight and obesity on coronary heart disease and stroke: pooled analysis of 97 prospective cohorts with 1.8 million participants

Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration (BMI Mediated Effect),
LANCET, 2014     DOI:10.1016/S0140-6736(13)61836-X

Reply to: Prediction of benefit from chemotherapy in ER-positive/HER2-negative breast cancer [letter]

Goldhirsch, A. Coates, A. S.

Pain in patients with cancer

Goodwin, P.J. Bruera, E. Stockler, M.
JOURNAL OF CLINICAL ONCOLOGY, 2014     DOI:10.1200/JCO.2014.55.3818

Cohort profile: the Men Androgen Inflammation Lifestyle Environment and Stress (MAILES) study

Grant, J. F. Martin, S. A. Taylor, A. W. Wilson, D. H. Araujo, A. Adams, R. J. Jenkins, A. Milne, R. W. Hugo, G. J. Atlantis, E. Wittert, G. A.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2014     DOI:10.1093/ije/dyt064

Unilateral versus bilateral clubfoot: an analysis of severity and correlation

Gray, K. Barnes, E. Gibbons, P. Little, D. Burns, J.
JOURNAL OF PEDIATRIC ORTHOPAEDICS B, 2014     DOI:10.1097/BPB.000000000000006

Pancreatic cancer hENT1 expression and survival from gemcitabine in patients from the ESPAC-3 trial

Greenhalf, W. Ghaneh, P. Neoptolemos, J. P. Palmer, D. H. Cox, T. F. Lamb, R. F. Garner, E. Campbell, F. Mackey, J. R. Costello, E. Moore, M. J. Valle, J. W. McDonald, A. C. Carter, R. Tebbutt, N. C. Goldstein, D. Shannon, J. Dervenis, C. Glimelius, B. Deakin, M. Charnley, R. M. Lacaine, F. Scarfe, A. G. Middleton, M. R. Anthoney, A. Halloran, C. M. Mayerle, J. Olah, A. Jackson, R. Rawcliffe, C. L. Scarpa, A. Bassi, C. Buchler, M. W. and for the European Study Group for Pancreatic Cancer,
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2014     DOI:10.1093/jnci/djt347

P3BEP companion translational study: prospective collection of whole blood, serum, plasma and tumour tissue in a randomized trial of chemotherapy for metastatic germ cell tumours

Grimison, P Stockler, MR Long, AP Yip, S Yeung, A Coskinas, X Toner, GC Horvath, LG

Accelerated BEP for metastatic germ cell tumours: a multicenter phase II trial by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP)

Grimison, P. S. Stockler, M. R. Chatfield, M. Thomson, D. B. Gebski, V. Friedlander, M. Boland, A. L. Houghton, B. Gurney, H. Rosenthal, M. Singhal, N. Kichenadasse, G. Wong, S. S. Lewis, C. R. Vasey, P. A. Toner, G. C. Australian and New Zealand Urogenital and Prostate Cancer Trials Group,
ANNALS OF ONCOLOGY, 2014     DOI:10.1093/annonc/mdt369

Circulating microRNAs: understanding the limits for quantitative measurement by real‐time PCR

Hardikar, A.A. Farr, R.J. Joglekar, M.V.
JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2014     DOI:10.1161/​JAHA.113.000792